1. Home
  2. PFSI vs TNGX Comparison

PFSI vs TNGX Comparison

Compare PFSI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSI

PennyMac Financial Services Inc.

HOLD

Current Price

$75.41

Market Cap

4.3B

Sector

Finance

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

BUY

Current Price

$27.18

Market Cap

4.5B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PFSI
TNGX
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
PFSI
TNGX
Price
$75.41
$27.18
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$128.11
$21.78
AVG Volume (30 Days)
512.2K
2.3M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
1.35%
N/A
EPS Growth
59.25
26.89
EPS
1.53
N/A
Revenue
$984,629,000.00
$62,384,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.96
N/A
P/E Ratio
$49.64
N/A
Revenue Growth
3.05
48.29
52 Week Low
$71.68
$6.21
52 Week High
$160.36
$34.39

Technical Indicators

Market Signals
Indicator
PFSI
TNGX
Relative Strength Index (RSI) 33.41 46.30
Support Level N/A $19.74
Resistance Level $87.40 $28.41
Average True Range (ATR) 2.66 1.59
MACD -0.77 -0.32
Stochastic Oscillator 23.42 31.58

Price Performance

Historical Comparison
PFSI
TNGX

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: